Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton

✍ Scribed by Vidya Soerdjbalie-Maikoe, Rob C. Pelger, Guus A. Lycklama à Nijeholt, Jan-Willem Arndt, Aeilko H. Zwinderman, Socrates E. Papapoulos, Neveen A. Hamdy

• Publisher: Springer
• Year: 2002
• Tongue: English
• Weight: 48 KB
• Volume: 29
• Category: Article
• ISSN: 0340-6997
• DOI: 10.1007/s00259-001-0728-7